Health and Fitness Health and Fitness
Thu, July 12, 2012
[ Thu, Jul 12th 2012 ] - Market Wire
Santa Fe Contracting for the Purchase of Leases i .. ver Five Million Barrels per the Engineer Studies
[ Thu, Jul 12th 2012 ] - Market Wire
Sanofi Biosurgery Product MACI Demonstrates Stati .. icant Clinical Outcomes Compared to Microfracture
[ Thu, Jul 12th 2012 ] - Market Wire
Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
[ Thu, Jul 12th 2012 ] - Market Wire
Sequenom, Inc. Announces Date Of Second Quarter 2012 Financial Results And Conference Call
[ Thu, Jul 12th 2012 ] - Market Wire
Implant Sciences Announces Follow-On Order to Africa for Hotel Security
[ Thu, Jul 12th 2012 ] - Market Wire
Theratechnologies Announces Financial Results for Second Quarter of 2012
[ Thu, Jul 12th 2012 ] - Market Wire
AVI BioPharma Announces Corporate Name Change to .. ck Ticker Symbol Change to "SRPT" Effective Today
[ Thu, Jul 12th 2012 ] - Market Wire
Record Revenues and Earnings for Greystone Logistics
Wed, July 11, 2012
[ Wed, Jul 11th 2012 ] - Market Wire
WuXi PharmaTech Schedules Second-Quarter 2012 Earnings Release
[ Wed, Jul 11th 2012 ] - Market Wire
Thallion Announces 2012 Second Quarter Results
[ Wed, Jul 11th 2012 ] - Market Wire
BD Announces Agreement to Acquire Safety Syringes, Inc.
[ Wed, Jul 11th 2012 ] - Market Wire
Arena Pharmaceuticals Files Marketing Authorizati .. for Lorcaserin as a Treatment for Weight Control
[ Wed, Jul 11th 2012 ] - Market Wire
Watson's Generic ARTHROTEC(R) Receives FDA Approval
[ Wed, Jul 11th 2012 ] - Market Wire
Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
[ Wed, Jul 11th 2012 ] - Market Wire
Hologic, Inc. Announces Note Offering
[ Wed, Jul 11th 2012 ] - Market Wire
Hologic And Gen-Probe Provide Update On Pending Transaction
[ Wed, Jul 11th 2012 ] - Market Wire
MSA Schedules Second Quarter Earnings Webcast
[ Wed, Jul 11th 2012 ] - Market Wire
Micro Imaging Technology to Showcase the MIT 1000 .. al Association for Food Protection Annual Meeting
[ Wed, Jul 11th 2012 ] - Market Wire
Comprehensive Care Named Among Top Florida Public Companies
[ Wed, Jul 11th 2012 ] - Market Wire
Global Green, Inc. Invited to Present at 2012 World Animal Health Congress
[ Wed, Jul 11th 2012 ] - Market Wire
Regeneron to Report Second Quarter 2012 Financial .. Host Conference Call and Webcast on July 25, 2012
[ Wed, Jul 11th 2012 ] - Market Wire
Oramed Pharmaceuticals Granted 2nd Patent in New .. for Core Technology on Oral Delivery of Proteins
[ Wed, Jul 11th 2012 ] - Market Wire
PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
[ Wed, Jul 11th 2012 ] - Market Wire
CryoLife Announces Release Date and Teleconferenc .. Details for 2012 Second Quarter Financial Results
[ Wed, Jul 11th 2012 ] - Market Wire
Medicaid Companies Surge After WellPoint's Acquisition of Amerigroup
[ Wed, Jul 11th 2012 ] - Market Wire
Centene and Molina Shares Soar After WellPoint Acquisition
[ Wed, Jul 11th 2012 ] - Market Wire
Echo Therapeutics Expands License Agreement with Ferndale Pharma
[ Wed, Jul 11th 2012 ] - Market Wire
Merus Labs International Inc. Announces Acquisition of Emselex(R)/Enablex(R)
[ Wed, Jul 11th 2012 ] - Market Wire
IsoRay Announces First International Orders for GliaSite Radiation Therapy System
[ Wed, Jul 11th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation .. d Webcast at JMP Securities Healthcare Conference

Threshold Pharmaceuticals Announces Presentation and Webcast at JMP Securities Healthcare Conference


Published on 2012-07-11 04:38:08 - Market Wire
  Print publication without navigation


July 11, 2012 07:30 ET

Threshold Pharmaceuticals Announces Presentation and Webcast at JMP Securities Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Jul 11, 2012) - Threshold Pharmaceuticals, Inc. (NASDAQ: [ THLD ]) today announced that Dr. Charles Hart, Vice President of Biology at Threshold, is scheduled to present at the JMP Securities Healthcare Conference on Friday, July 13, at 10:30 am Eastern time in New York City.

A live webcast of the presentation will be available under Webcasts in the Investors section of [ www.thresholdpharm.com ]. A replay of the presentation will be archived on the site for 30 days.

About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, Threshold is building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit [ www.thresholdpharm.com ].


Contributing Sources